APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dystrophin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dystrophin Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchDystrophin Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Dystrophin Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Dystrophin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dystrophin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Dystrophin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Dystrophin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dystrophin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dystrophin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dystrophin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dystrophin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dystrophin market include Pfizer Inc, Daiichi Sankyo Company Ltd, WAVE Life Sciences Ltd, Sarepta Therapeutics Inc, Nippon Shinyaku Co Ltd, Genethon SA, Editas Medicine Inc, BioMarin Pharmaceutical Inc and Asklepios BioPharmaceutical Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dystrophin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dystrophin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dystrophin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dystrophin market size, projected growth trends, production technologies, key applications, and end-use industries.

Dystrophin Segment by Company

Pfizer Inc

Daiichi Sankyo Company Ltd

WAVE Life Sciences Ltd

Sarepta Therapeutics Inc

Nippon Shinyaku Co Ltd

Genethon SA

Editas Medicine Inc

BioMarin Pharmaceutical Inc

Asklepios BioPharmaceutical Inc

Dystrophin Segment by Type

DS-5141

Biostrophin

BMBD-001

NS-065

Others

Dystrophin Segment by Application

Genetic Disorders

Musculoskeletal Disorders

Others

Dystrophin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dystrophin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dystrophin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dystrophin significant trends, drivers, influence factors in global and regions.

6. To analyze Dystrophin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dystrophin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dystrophin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dystrophin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dystrophin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dystrophin industry.

Chapter 3: Detailed analysis of Dystrophin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dystrophin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dystrophin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dystrophin Industry Trends Table 2. Dystrophin Industry Drivers Table 3. Dystrophin Industry Opportunities and Challenges Table 4. Dystrophin Industry Restraints Table 5. Global Dystrophin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dystrophin Revenue Share by Company (2021-2026) Table 7. Global Dystrophin Sales Volume by Company (k units) & (2021-2026) Table 8. Global Dystrophin Sales Volume Share by Company (2021-2026) Table 9. Global Dystrophin Average Price (US$/unit) of Company (2021-2026) Table 10. Global Dystrophin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dystrophin Key Company Manufacturing Base & Headquarters Table 12. Global Dystrophin Company, Product Type & Application Table 13. Global Dystrophin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dystrophin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of DS-5141 Table 18. Significant Companies of Biostrophin Table 19. Significant Companies of BMBD-001 Table 20. Significant Companies of NS-065 Table 21. Significant Companies of Others Table 22. Global Dystrophin Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Dystrophin Sales Volume by Type (2021-2026) & (k units) Table 24. Global Dystrophin Sales Volume by Type (2027-2032) & (k units) Table 25. Global Dystrophin Sales Volume Share by Type (2021-2026) Table 26. Global Dystrophin Sales Volume Share by Type (2027-2032) Table 27. Global Dystrophin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Dystrophin Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Dystrophin Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Dystrophin Sales Value Share by Type (2021-2026) Table 31. Global Dystrophin Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Genetic Disorders Table 33. Significant Companies of Musculoskeletal Disorders Table 34. Significant Companies of Others Table 35. Global Dystrophin Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Dystrophin Sales Volume by Application (2021-2026) & (k units) Table 37. Global Dystrophin Sales Volume by Application (2027-2032) & (k units) Table 38. Global Dystrophin Sales Volume Share by Application (2021-2026) Table 39. Global Dystrophin Sales Volume Share by Application (2027-2032) Table 40. Global Dystrophin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Dystrophin Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Dystrophin Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Dystrophin Sales Value Share by Application (2021-2026) Table 44. Global Dystrophin Sales Value Share by Application (2027-2032) Table 45. Global Dystrophin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Dystrophin Sales by Region (2021-2026) & (k units) Table 47. Global Dystrophin Sales Market Share by Region (2021-2026) Table 48. Global Dystrophin Sales by Region (2027-2032) & (k units) Table 49. Global Dystrophin Sales Market Share by Region (2027-2032) Table 50. Global Dystrophin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Dystrophin Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Dystrophin Sales Value Share by Region (2021-2026) Table 53. Global Dystrophin Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Dystrophin Sales Value Share by Region (2027-2032) Table 55. Global Dystrophin Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Dystrophin Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Dystrophin Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Dystrophin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Dystrophin Sales by Country (2021-2026) & (k units) Table 60. Global Dystrophin Sales Market Share by Country (2021-2026) Table 61. Global Dystrophin Sales by Country (2027-2032) & (k units) Table 62. Global Dystrophin Sales Market Share by Country (2027-2032) Table 63. Global Dystrophin Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Dystrophin Sales Value Market Share by Country (2021-2026) Table 65. Global Dystrophin Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Dystrophin Sales Value Market Share by Country (2027-2032) Table 67. Pfizer Inc Company Information Table 68. Pfizer Inc Business Overview Table 69. Pfizer Inc Dystrophin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Pfizer Inc Dystrophin Product Portfolio Table 71. Pfizer Inc Recent Development Table 72. Daiichi Sankyo Company Ltd Company Information Table 73. Daiichi Sankyo Company Ltd Business Overview Table 74. Daiichi Sankyo Company Ltd Dystrophin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Daiichi Sankyo Company Ltd Dystrophin Product Portfolio Table 76. Daiichi Sankyo Company Ltd Recent Development Table 77. WAVE Life Sciences Ltd Company Information Table 78. WAVE Life Sciences Ltd Business Overview Table 79. WAVE Life Sciences Ltd Dystrophin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. WAVE Life Sciences Ltd Dystrophin Product Portfolio Table 81. WAVE Life Sciences Ltd Recent Development Table 82. Sarepta Therapeutics Inc Company Information Table 83. Sarepta Therapeutics Inc Business Overview Table 84. Sarepta Therapeutics Inc Dystrophin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Sarepta Therapeutics Inc Dystrophin Product Portfolio Table 86. Sarepta Therapeutics Inc Recent Development Table 87. Nippon Shinyaku Co Ltd Company Information Table 88. Nippon Shinyaku Co Ltd Business Overview Table 89. Nippon Shinyaku Co Ltd Dystrophin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Nippon Shinyaku Co Ltd Dystrophin Product Portfolio Table 91. Nippon Shinyaku Co Ltd Recent Development Table 92. Genethon SA Company Information Table 93. Genethon SA Business Overview Table 94. Genethon SA Dystrophin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Genethon SA Dystrophin Product Portfolio Table 96. Genethon SA Recent Development Table 97. Editas Medicine Inc Company Information Table 98. Editas Medicine Inc Business Overview Table 99. Editas Medicine Inc Dystrophin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Editas Medicine Inc Dystrophin Product Portfolio Table 101. Editas Medicine Inc Recent Development Table 102. BioMarin Pharmaceutical Inc Company Information Table 103. BioMarin Pharmaceutical Inc Business Overview Table 104. BioMarin Pharmaceutical Inc Dystrophin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. BioMarin Pharmaceutical Inc Dystrophin Product Portfolio Table 106. BioMarin Pharmaceutical Inc Recent Development Table 107. Asklepios BioPharmaceutical Inc Company Information Table 108. Asklepios BioPharmaceutical Inc Business Overview Table 109. Asklepios BioPharmaceutical Inc Dystrophin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Asklepios BioPharmaceutical Inc Dystrophin Product Portfolio Table 111. Asklepios BioPharmaceutical Inc Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Dystrophin Distributors List Table 115. Dystrophin Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Dystrophin Product Image Figure 2. Global Dystrophin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dystrophin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dystrophin Sales (2021-2032) & (k units) Figure 5. Global Dystrophin Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Dystrophin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. DS-5141 Image Figure 10. Biostrophin Image Figure 11. BMBD-001 Image Figure 12. NS-065 Image Figure 13. Others Image Figure 14. Global Dystrophin Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Dystrophin Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Dystrophin Sales Volume Share by Type (2021-2032) Figure 17. Global Dystrophin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Dystrophin Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Dystrophin Sales Value Share by Type (2021-2032) Figure 20. Genetic Disorders Image Figure 21. Musculoskeletal Disorders Image Figure 22. Others Image Figure 23. Global Dystrophin Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Dystrophin Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Dystrophin Sales Volume Share by Application (2021-2032) Figure 26. Global Dystrophin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Dystrophin Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Dystrophin Sales Value Share by Application (2021-2032) Figure 29. Global Dystrophin Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Dystrophin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Dystrophin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Dystrophin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Dystrophin Sales Value (2021-2032) & (US$ Million) Figure 34. North America Dystrophin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Dystrophin Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Dystrophin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Dystrophin Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Dystrophin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Dystrophin Sales Value (2021-2032) & (US$ Million) Figure 40. South America Dystrophin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Dystrophin Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Dystrophin Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Dystrophin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Dystrophin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Dystrophin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Dystrophin Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Dystrophin Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • DS-5141
  • Biostrophin
  • BMBD-001
  • NS-065
  • Others
Applications
  • Genetic Disorders
  • Musculoskeletal Disorders
  • Others
Companies covered
  • Pfizer Inc
  • Daiichi Sankyo Company Ltd
  • WAVE Life Sciences Ltd
  • Sarepta Therapeutics Inc
  • Nippon Shinyaku Co Ltd
  • Genethon SA
  • Editas Medicine Inc
  • BioMarin Pharmaceutical Inc
  • Asklepios BioPharmaceutical Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dystrophin Sales Value (2021-2032)
  4. 1.2.2 Global Dystrophin Sales Volume (2021-2032)
  5. 1.2.3 Global Dystrophin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dystrophin Market Dynamics
  1. 2.1 Dystrophin Industry Trends
  2. 2.2 Dystrophin Industry Drivers
  3. 2.3 Dystrophin Industry Opportunities and Challenges
  4. 2.4 Dystrophin Industry Restraints
3 Dystrophin Market by Company
  1. 3.1 Global Dystrophin Company Revenue Ranking in 2025
  2. 3.2 Global Dystrophin Revenue by Company (2021-2026)
  3. 3.3 Global Dystrophin Sales Volume by Company (2021-2026)
  4. 3.4 Global Dystrophin Average Price by Company (2021-2026)
  5. 3.5 Global Dystrophin Company Ranking (2024-2026)
  6. 3.6 Global Dystrophin Company Manufacturing Base and Headquarters
  7. 3.7 Global Dystrophin Company Product Type and Application
  8. 3.8 Global Dystrophin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dystrophin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dystrophin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dystrophin Market by Type
  1. 4.1 Dystrophin Type Introduction
  2. 4.1.1 DS-5141
  3. 4.1.2 Biostrophin
  4. 4.1.3 BMBD-001
  5. 4.1.4 NS-065
  6. 4.1.5 Others
  7. 4.2 Global Dystrophin Sales Volume by Type
  8. 4.2.1 Global Dystrophin Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Dystrophin Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Dystrophin Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Dystrophin Sales Value by Type
  12. 4.3.1 Global Dystrophin Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Dystrophin Sales Value by Type (2021-2032)
  14. 4.3.3 Global Dystrophin Sales Value Share by Type (2021-2032)
5 Dystrophin Market by Application
  1. 5.1 Dystrophin Application Introduction
  2. 5.1.1 Genetic Disorders
  3. 5.1.2 Musculoskeletal Disorders
  4. 5.1.3 Others
  5. 5.2 Global Dystrophin Sales Volume by Application
  6. 5.2.1 Global Dystrophin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dystrophin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Dystrophin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Dystrophin Sales Value by Application
  10. 5.3.1 Global Dystrophin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dystrophin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Dystrophin Sales Value Share by Application (2021-2032)
6 Dystrophin Regional Sales and Value Analysis
  1. 6.1 Global Dystrophin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dystrophin Sales by Region (2021-2032)
  3. 6.2.1 Global Dystrophin Sales by Region: 2021-2026
  4. 6.2.2 Global Dystrophin Sales by Region (2027-2032)
  5. 6.3 Global Dystrophin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dystrophin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dystrophin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dystrophin Sales Value by Region (2027-2032)
  9. 6.5 Global Dystrophin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dystrophin Sales Value (2021-2032)
  12. 6.6.2 North America Dystrophin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dystrophin Sales Value (2021-2032)
  15. 6.7.2 Europe Dystrophin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dystrophin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dystrophin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dystrophin Sales Value (2021-2032)
  21. 6.9.2 South America Dystrophin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dystrophin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dystrophin Sales Value Share by Country, 2025 VS 2032
7 Dystrophin Country-level Sales and Value Analysis
  1. 7.1 Global Dystrophin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dystrophin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dystrophin Sales by Country (2021-2032)
  4. 7.3.1 Global Dystrophin Sales by Country (2021-2026)
  5. 7.3.2 Global Dystrophin Sales by Country (2027-2032)
  6. 7.4 Global Dystrophin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dystrophin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dystrophin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dystrophin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dystrophin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dystrophin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dystrophin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dystrophin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dystrophin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dystrophin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dystrophin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dystrophin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dystrophin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dystrophin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dystrophin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dystrophin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dystrophin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dystrophin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dystrophin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dystrophin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dystrophin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dystrophin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dystrophin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dystrophin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dystrophin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dystrophin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dystrophin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dystrophin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dystrophin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dystrophin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dystrophin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dystrophin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dystrophin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dystrophin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dystrophin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dystrophin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dystrophin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dystrophin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dystrophin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dystrophin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dystrophin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dystrophin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dystrophin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dystrophin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dystrophin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dystrophin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dystrophin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dystrophin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dystrophin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dystrophin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dystrophin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dystrophin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dystrophin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dystrophin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dystrophin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dystrophin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dystrophin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dystrophin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dystrophin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dystrophin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dystrophin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dystrophin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dystrophin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dystrophin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dystrophin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dystrophin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dystrophin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dystrophin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dystrophin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dystrophin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dystrophin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dystrophin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dystrophin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dystrophin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dystrophin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dystrophin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dystrophin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dystrophin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dystrophin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dystrophin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dystrophin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dystrophin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dystrophin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dystrophin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dystrophin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dystrophin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dystrophin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer Inc
  2. 8.1.1 Pfizer Inc Company Information
  3. 8.1.2 Pfizer Inc Business Overview
  4. 8.1.3 Pfizer Inc Dystrophin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Inc Dystrophin Product Portfolio
  6. 8.1.5 Pfizer Inc Recent Developments
  7. 8.2 Daiichi Sankyo Company Ltd
  8. 8.2.1 Daiichi Sankyo Company Ltd Company Information
  9. 8.2.2 Daiichi Sankyo Company Ltd Business Overview
  10. 8.2.3 Daiichi Sankyo Company Ltd Dystrophin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Daiichi Sankyo Company Ltd Dystrophin Product Portfolio
  12. 8.2.5 Daiichi Sankyo Company Ltd Recent Developments
  13. 8.3 WAVE Life Sciences Ltd
  14. 8.3.1 WAVE Life Sciences Ltd Company Information
  15. 8.3.2 WAVE Life Sciences Ltd Business Overview
  16. 8.3.3 WAVE Life Sciences Ltd Dystrophin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 WAVE Life Sciences Ltd Dystrophin Product Portfolio
  18. 8.3.5 WAVE Life Sciences Ltd Recent Developments
  19. 8.4 Sarepta Therapeutics Inc
  20. 8.4.1 Sarepta Therapeutics Inc Company Information
  21. 8.4.2 Sarepta Therapeutics Inc Business Overview
  22. 8.4.3 Sarepta Therapeutics Inc Dystrophin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sarepta Therapeutics Inc Dystrophin Product Portfolio
  24. 8.4.5 Sarepta Therapeutics Inc Recent Developments
  25. 8.5 Nippon Shinyaku Co Ltd
  26. 8.5.1 Nippon Shinyaku Co Ltd Company Information
  27. 8.5.2 Nippon Shinyaku Co Ltd Business Overview
  28. 8.5.3 Nippon Shinyaku Co Ltd Dystrophin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nippon Shinyaku Co Ltd Dystrophin Product Portfolio
  30. 8.5.5 Nippon Shinyaku Co Ltd Recent Developments
  31. 8.6 Genethon SA
  32. 8.6.1 Genethon SA Company Information
  33. 8.6.2 Genethon SA Business Overview
  34. 8.6.3 Genethon SA Dystrophin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Genethon SA Dystrophin Product Portfolio
  36. 8.6.5 Genethon SA Recent Developments
  37. 8.7 Editas Medicine Inc
  38. 8.7.1 Editas Medicine Inc Company Information
  39. 8.7.2 Editas Medicine Inc Business Overview
  40. 8.7.3 Editas Medicine Inc Dystrophin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Editas Medicine Inc Dystrophin Product Portfolio
  42. 8.7.5 Editas Medicine Inc Recent Developments
  43. 8.8 BioMarin Pharmaceutical Inc
  44. 8.8.1 BioMarin Pharmaceutical Inc Company Information
  45. 8.8.2 BioMarin Pharmaceutical Inc Business Overview
  46. 8.8.3 BioMarin Pharmaceutical Inc Dystrophin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BioMarin Pharmaceutical Inc Dystrophin Product Portfolio
  48. 8.8.5 BioMarin Pharmaceutical Inc Recent Developments
  49. 8.9 Asklepios BioPharmaceutical Inc
  50. 8.9.1 Asklepios BioPharmaceutical Inc Company Information
  51. 8.9.2 Asklepios BioPharmaceutical Inc Business Overview
  52. 8.9.3 Asklepios BioPharmaceutical Inc Dystrophin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Asklepios BioPharmaceutical Inc Dystrophin Product Portfolio
  54. 8.9.5 Asklepios BioPharmaceutical Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dystrophin Value Chain Analysis
  2. 9.1.1 Dystrophin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dystrophin Sales Mode & Process
  6. 9.2 Dystrophin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dystrophin Distributors
  9. 9.2.3 Dystrophin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst